FDA approves CyPass Micro-Stent

The CyPass® Micro-Stent is a minimally invasive device that can be implanted at the time of cataract surgery. About 20% of patients undergoing cataract surgery also have glaucoma, leading to a large number of patients who could conveniently receive combined therapy.

FDA has approved CyPass micro stent from Alcon Laboratories.

Continue reading